Time for Broader Adoption of SGLT2 Inhibitors in Clinical Practice?
Saved in:
| Title: | Time for Broader Adoption of SGLT2 Inhibitors in Clinical Practice? |
|---|---|
| Authors: | Gregg LP; Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas.; Renal Section, Medical Care Line, Michael E. DeBakey VA Medical Center, Houston, Texas., Bozkurt B; Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas.; Winters Center for Heart Failure Research, Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Medical Care Line, Michael E. DeBakey VA Medical Center, Houston, Texas., Navaneethan SD; Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey VA Medical Center, Houston, Texas.; Renal Section, Medical Care Line, Michael E. DeBakey VA Medical Center, Houston, Texas.; Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas. |
| Source: | JAMA [JAMA] 2026 Jan 20; Vol. 335 (3), pp. 217-219. |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
